Table 6.
Evaluation of variables in survivors and non survivors
| Variable | Survivors (n = 76) | Non survivors (n = 20) | p value |
|---|---|---|---|
| Lactate (IQR) | 3.0 (20-4.8) | 13.4 (9.45-7.5) | <0.01 |
| Aspertate Transaminase (IQR) | 299.5 (148-1098.5) | 4936 (2431.5-14340.3) | <0.01 |
| Alanine Transaminase (IQR) | 163 (83.75-469.5) | 1412 (613-3832.75) | <0.01 |
| Base Excess | -3.75 (-1.42-6.57) | -21.9 (-18.2- -24.0) | <0.01 |
| Platelets (mean ±SD) | 22493.4 (24405.3) | 19200 (15949.3) | 0.864 |
| Total count (mean ±SD) | 8258 (6032) | (13453 (10799.9) | 0.095 |
| Hematocrit (mean ±SD) | 41.5 (9.84) | 43.2 (9.54) | 0.332 |
| Serum albumin (g/dL), (mean ±SD) | 2.67 (0.62) | 2.44 (0.7) | 0.264 |
| APACHE median (IQR) | 6.0 (4.0-9.0) | 17.5 (9.5-35.75) | <0.01 |
| SOFA 48 hours median (IQR) | 6 (3.0-20.0) | 20 (18-22) | <0.01 |